Chemical Compound
2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-; (-)-Sch 58235; 1-(4-Fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one; Ezedoc; Ezentia; Ezetimibe; Ezetrol; Ezta; Sch 58235; Zetia
CAS Registry Number
163222-33-1
Primary record
2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-; (-)-Sch 58235; 1-(4-Fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one; Ezedoc; Ezentia; Ezetimibe; Ezetrol; Ezta; Sch 58235; Zetia
- 库存
- 7,687 克
- 纯度
- 99.0 %
- CAS
- 163222-33-1
化合物标识与属性
- CAS
- 163222-33-1
- PubChem CID
- 150311
- SMILES
- C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O
- Canonical SMILES
- O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1
名称与同义词
- Ezetimibe
- Zetia
- Ezetrol
- Ezedoc
- 163222-33-1
- ezetimib
- ezetimiba
- ezentia
- ezetimibum
- Vytorin
- Zient
- Ezta
- Ezetimibe)
- Mixture Name
- Ezetimibe-d4
- Zetia ;Ezetrol
- Sch 58235
- ezetimibe anhydrate
- Ezetimibe (Standard)
- Zetia (TN)
- Ezetimibe (Zetia)
- Ezetimibe-13C6
- Ezetimibe [USAN:INN]
- Vytorin (TN)
- Ezetimibe [USAN]
- ent-Ezetimibe Ketone
- SCH58235
- MSD brand of ezetimibe
- SCH-58235
- Ezetimibe (Zetia)?
- Inegy (TN)
- Essex brand of ezetimibe
- Merck brand of ezetimibe
- C24H21F2NO3
- EOR26LQQ24
- Ezetimibe Impurity 66
- EZETIMIBE [INN]
- EZETIMIBE [JAN]
- RefChem:56736
- UNII-EOR26LQQ24
- EZETIMIBE [MI]
- MFCD00937872
- EZETIMIBE [HSDB]
- EZETIMIBE [VANDF]
- DTXSID1044223
- Ezetimibe [USAN:INN:BAN]
- D09LWS
- EZETIMIBE [MART.]
- EZETIMIBE [USP-RS]
- EZETIMIBE [WHO-DD]
- SCHEMBL2871
- K-924 component Ezetimibe
- Zetia , Ezetrol, Ezetimibe
- (3'R)-Ezetimibe
- CHEMBL1138
- Ezetimibe (JAN/USP/INN)
- (-)-Sch 58235
- DTXCID9024223
- cc-336
- CHEBI:49040
- Ezetimibe (JAN/USAN/INN)
- HSDB 7737
- MLS000759443
- MLS001424125
- MLS006011921
- ROSZET COMPONENT EZETIMIBE
- Ezetimibe - Bio-X trade mark
- (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
- MK0653
- VYTORIN COMPONENT EZETIMIBE
- AC1L442L
- GTPL6816
- NEXLIZET COMPONENT EZETIMIBE
- orb1308079
- Schering-Plough brand of ezetimibe
- EZETIMIBE [ORANGE BOOK]
- Ezetimibe, >=98% (HPLC)
- NSC-758923
- ERK5-3P05
- C10AX09
- EX-A795
- EZETIMIBE [USP MONOGRAPH]
- OLNTVTPDXPETLC-XPWALMASSA-N
- GLXC-05134
- HMS2051K16
- HMS2236A04
- HMS3715D06
- 58235, SCH
- Ezetimibe, 98% - 10mg 10mg
- ACT03511
- AMX10142
- MK-0653
- MSK10712
- ZINC3810860
- Tox21_111443
- (-)-Sch-58235
- ABP001091
- BDBM50371521
- C24-H21-F2-N-O3
- CID150311
- EBC-09095
- HY-17376R
- NP3280
- s1655
- STK640490
- AKOS005572111
- Tox21_111443_1
- AC-1057
- ACN-034430
- AM84560
- AN-5188
- CCG-100884
- CID:150311
- CS-1016
- CS-P-02363
- DB00973
- FE23215
- KS-1170
- NC00134
- NSC 758923
- RL02093
- NCGC00095134-01
- NCGC00263575-01
- NCGC00263575-07
- (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
- BC216471
- BE164439
- CPD000466334
- HY-17376
- SAM001246623
- SC-17354
- SMR000466334
- SY028053
- SID:283537528
- 2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-
- AB0011316
- AB2000199
- J900.924H
- LS-181801
- CAS-163222-33-1
- CS-0694785
- E1449
- FT-0601590
- FT-0668448
- FT-0668449
- FT-0668450
- NS00008042
- A10379
- D01966
- EN300-122361
- K-5098
- 28055-EP2272841A1
- 28055-EP2280001A1
- 28055-EP2287165A2
- 28055-EP2287166A2
- 28055-EP2292620A2
- 28055-EP2294052A1
- 28055-EP2295422A2
- 28055-EP2298742A1
- 28055-EP2298769A1
- 28055-EP2298776A1
- 28055-EP2301923A1
- 28055-EP2301936A1
- 28055-EP2308878A2
- 28055-EP2314588A1
- AB00639916-06
- AB00639916-08
- AB00639916_09
- 222E331
- A810456
- AR-270/43507897
- C108606
- Q417997
- BRD-K42260897-001-07-6
- BRD-K42260897-001-09-2
- (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one
- 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone
- D000069438
- Z1541759501
- (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone)
- (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone
- 2-Azetidinone, 1-(4-fluorophenyl)-3-((3S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-, (3R,4S)-
- 2-Azetidinone, 1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-, (3R-(3alpha(S*),4beta))-
- Ezetimibe, United States Pharmacopeia (USP) Reference Standard
- 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione
- (3~{R},4~{S})-1-(4-fluorophenyl)-3-[(3~{S})-3-(4-fluorophenyl)-3-oxidanyl-propyl]-4-(4-hydroxyphenyl)azetidin-2-one
- Ezetimibe, Pharmaceutical Secondary Standard; Certified Reference Material
- (3R)-1-(4-Fluorophenyl)-3alpha-[(S)-3-hydroxy-3-(4-fluorophenyl)propyl]-4beta-(4-hydroxyphenyl)-2-azetidinone
- (3R)-1-(4-Fluorophenyl)-3alpha-[(S)-3-hydroxy-3-(4-fluorophenyl)propyl]-4beta-(4-hydroxyphenyl)azetidin-2-one
- (3R,4S)-1-(4-Fluorophenyl)-3-((3S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
- (3R,4S)-1-(4-fluorophenyl)-3-[(3 S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
- (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)- 3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
- (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyp henyl)-2-Azetidinone
- (3r,4s)-1-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
- (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone, Sch 58235
- (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
- (3R,4S)-1-(4-Fluorophenyl)-3-[(S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
- (3R,4S)-1-(4-Fluorophenyl)-3-[(S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-azetidin-2-one
- (3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
- (3R,4S)-3-[(S)-3-Hydroxy-3-(4-fluorophenyl)propyl]-1-(4-fluorophenyl)-4-(4-hydroxyphenyl)-2-azetidinone
- 1-(4-fluorophenyl)-3(R)-(3-(4-fluorophenyl)-3(S)-hydroxypropyl)-4(S)-(4-hydroxyphenyl)-2-azetidinone
- 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
- 1093659-90-5
- 163380-16-3
- 2-azetidinona, 1-(4-fluorofenil)-3-[(3s)-3-(4-fluorofenil)-3-hidroxipropil]-4-(4-hidroxifenil)-, (3r,4s)-
- 2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-; (-)-Sch 58235; 1-(4-Fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one; Ezedoc; Ezentia; Ezetimibe; Ezetrol; Ezta; Sch 58235; Zetia
- 204589-68-4
- 438624-68-1
- 682-606-0
- 947332-80-1
- H56